Importer of Controlled Substances Application: Chattem Chemicals, Inc., 46716-46717 [2021-17764]
Download as PDF
<![CDATA[
46716
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All nonconfidential written
submissions will be available for public
inspection on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and Part 210 of the Commission’s Rules
of Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: August 16, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–17816 Filed 8–18–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–887]
Importer of Controlled Substances
Application: Galephar Pharmaceutical
Research Inc.
lotter on DSK11XQN23PROD with NOTICES1
17:28 Aug 18, 2021
Jkt 253001
Hydromorphone ..............
Schedule
I 9150 III
The company plans to import the
listed controlled substance in finished
dosage form for analytical purpose only.
No other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
BILLING CODE 4410–09–P
Galephar has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 20, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 20, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
VerDate Sep<11>2014
Drug
code
Controlled substance
[FR Doc. 2021–17765 Filed 8–18–21; 8:45 am]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SUMMARY:
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2021, Galephar
Pharmaceutical Research Inc., 100 Carr
198 Industrial Park, Juncos, Puerto Rico
00777–3873, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–886]
Importer of Controlled Substances
Application: Chattem Chemicals, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chattem Chemicals, Inc., has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 20, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 20, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2021, Chattem
Chemicals, Inc., 3801 Saint Elmo
Avenue, Chattanooga, Tennessee
37409–1237, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Methamphetamine ...........
4-Anilino-N-Phenethyl-4Piperidine (ANPP).
Phenylacetone .................
Coca Leaves ...................
Opium, Raw .....................
Poppy Straw Concentrate
Tapentadol ......................
Drug
code
Schedule
1105
8333
II
II
8501
9040
9600
9670
9780
II
II
II
II
II
The company plans to import the listed
controlled substances to manufacture
bulk controlled substances for sale to its
customers. The company plans to
import an intermediate of Tapentadol
(9780), to bulk manufacture Tapentadol
for distribution to its customers. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
E:\FR\FM\19AUN1.SGM
19AUN1
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices
approved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–17764 Filed 8–18–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Office of Disability Employment Policy
Agency Information Collection
Activities; Comment Request; Job
Accommodation Network Customer
Satisfaction Questionnaire
Notice of information
collections and request for comments.
lotter on DSK11XQN23PROD with NOTICES1
ACTION:
SUMMARY: In compliance with the
Paperwork Reduction Act of 1995, the
DOL is soliciting public comments
regarding this ODEP-sponsored
information collection to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments pertaining to this
information collection are due on or
before October 18, 2021.
ADDRESSES: Electronic submission: You
may submit comments and attachments
electronically at https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Mail submission: 200 Constitution
Ave. NW, Room S–5315, Washington,
DC 20210. Comments are invited on: (1)
Whether the collection of information is
necessary for the proper performance of
the functions of the DOL, including
whether the information will have
practical utility; (2) if the information
will be processed and used in a timely
manner; (3) the accuracy of the DOL’s
estimates of the burden and cost of the
collection of information, including the
validity of the methodology and
assumptions used; (4) ways to enhance
the quality, utility and clarity of the
information collection; and (5) ways to
minimize the burden of the collection of
information on those who are to
respond, including the use of automated
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT:
Betsy Kravitz by telephone at 202–693–
7860 (this is not a toll-free number) or
by email at DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The Job
Accommodation Network (JAN) is a
leading source of guidance on job
accommodations and disability
employment issues and has served
customers for more than 35 years. JAN
provides free one-on-one practical
guidance and technical assistance on job
VerDate Sep<11>2014
17:28 Aug 18, 2021
Jkt 253001
accommodation solutions, Title I of the
Americans with Disabilities Act (ADA)
and related legislation, and selfemployment and entrepreneurship
options for people with disabilities. JAN
provides individualized consultation to
assist:
• Employers and their representatives
seeking guidance on practical ways to
engage in the interactive process,
provide job accommodation solutions,
and comply with Title I of the ADA;
• Individuals with medical
conditions and disabilities seeking
information about job accommodation
solutions, employment rights under the
ADA, and self-employment and
entrepreneurship opportunities; and
• Family members and rehabilitation,
medical, educational, and other
professionals in their effort to support
successful employment outcomes for
individuals with medical conditions
and disabilities.
JAN customers (employer
representatives, service providers, and
individuals with disabilities) who
contact JAN via phone calls, email, and
internet chats and who have inquiries
related to workplace accommodation or
self-employment issues will be asked to
participate in the Customer Satisfaction
Questionnaire, which is sent via email.
The initial email requesting
participation includes the Informed
Consent script used by both JAN and the
West Virginia University School of
Social Work. Informed consent specifies
that the purpose is to evaluate JAN’s
services and to identify ways in which
services can be improved to assist
clients. Potential participants also will
be informed that their decision to either
participate or refuse to participate will
in no way impact their ability to use
JAN’s services in the future. Following
the link to complete the questionnaire is
considered consent. Customers can also
opt out of further contacts or choose to
contact the evaluator directly if there are
questions or concerns. The statement
has been approved by the West Virginia
University Internal Review Board. The
questionnaire requests demographic
information, accommodation process
details and costs, and general
satisfaction items. Respondents can
choose to answer or skip each item.
This information collection is subject
to the Paperwork Reduction Act (PRA).
A Federal agency generally cannot
conduct or sponsor a collection of
information, and the public is generally
not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
46717
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
The DOL seeks PRA authorization for
this information collection for three (3)
years. OMB authorization for an
Information Collection Review cannot
be for more than three (3) years without
renewal. The DOL notes that currently
approved information collection
requirements submitted to the OMB
receive a month-to-month extension
while they undergo review.
Agency: DOL–ODEP.
Type of Review: New information
collection.
Title of Collection: Job
Accommodation Network (JAN)
Customer Satisfaction Questionnaire.
OMB Control Number: 1230–0NEW.
Affected Public: Individuals or
Households.
Total Estimated Number of
Respondents: 1,680.
Frequency: Once per customer every 6
months.
Total Estimated Number of
Responses: 1,680.
Total Estimated Annual Time Burden:
420 hours.
Total Estimated Annual Other Costs
Burden: $0.
Authority: 44 U.S.C. 3506(c)(2)(A).
Dated: August 12, 2021.
Jennifer Sheehy,
Deputy Assistant Secretary, Office of
Disability Employment Policy.
[FR Doc. 2021–17787 Filed 8–18–21; 8:45 am]
BILLING CODE 4510–FK–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Determinations Regarding Eligibility
To Apply for Trade Adjustment
Assistance
In accordance with Sections 223 and
284 (19 U.S.C. 2273 and 2395) of the
Trade Act of 1974 (19 U.S.C. 2271, et
seq.) (‘‘Act’’), as amended, the
Department of Labor herein presents
summaries of determinations regarding
eligibility to apply for trade adjustment
assistance under Chapter 2 of the Act
(‘‘TAA’’) for workers by (TA–W) issued
during the period of July 1 2021 through
July 31 2021.
This notice includes summaries of
initial determinations such as
Affirmative Determinations of
Eligibility, Negative Determinations of
Eligibility, and Determinations
Terminating Investigations of Eligibility
within the period. If issued in the
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 86, Number 158 (Thursday, August 19, 2021)]
[Notices]
[Pages 46716-46717]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17764]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-886]
Importer of Controlled Substances Application: Chattem Chemicals,
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chattem Chemicals, Inc., has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before September 20,
2021. Such persons may also file a written request for a hearing on the
application on or before September 20, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2021, Chattem Chemicals, Inc., 3801 Saint
Elmo Avenue, Chattanooga, Tennessee 37409-1237, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Methamphetamine......................... 1105 II
4-Anilino-N-Phenethyl-4-Piperidine 8333 II
(ANPP).
Phenylacetone........................... 8501 II
Coca Leaves............................. 9040 II
Opium, Raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers. The
company plans to import an intermediate of Tapentadol (9780), to bulk
manufacture Tapentadol for distribution to its customers. No other
activity for this drug code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-
[[Page 46717]]
approved finished dosage forms for commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-17764 Filed 8-18-21; 8:45 am]
BILLING CODE P
